Fluorotechnics expands global capability via acquisition of ETC Elektrophorese-Technik
Fluorotechnics announced the acquisition of ETC Elektrophorese-Technik. Under the terms of the acquisition, Fluorotechnics will acquire all issued shares in ETC Elektrophorese-Technik in exchange for Fluorotechnics shares. ETC Elektrophorese-Technik develops and manufactures high-end electrophoresis consumables and equipment used for diagnostics, quality control and species identification.
Fluorotechnics CEO, Duncan Veal, states, "We are very excited by the synergies that the combination of the two companies will bring. This acquisition will allow us to cross-sell products to existing customers and to address new markets utilizing our joint expertise. Our ever-expanding sales and marketing team and enormous potential for our product offering means that we are well positioned for strong growth."
The integrated company will retain its manufacturing bases in Sydney, Australia and Kirchentellinsfurt, Germany. Duncan Veal will continue as CEO, Hanspeter Schickle, CEO of ETC, will become head of product development in electrophoresis, and Günter Theßeling, a recent appointment from GE Healthcare, will spearhead the sales and marketing drive.
Other news from the department business & finance
